Utilization Patterns of Single-Fraction and Short- Course Radiotherapeutic Schedules in the Management of Bone Metastases

被引:1
|
作者
Koduri, Sravya [1 ]
Abel, Stephen [2 ]
Bergin, John [2 ]
Fuhrer, Russell [2 ]
Beriwal, Sushil [2 ]
Wegner, Rodney E. [2 ]
机构
[1] Lankenau Med Ctr, Dept Med, Philadelphia, PA USA
[2] Allegheny Hlth Network Canc Inst, Div Radiat Oncol, Pittsburgh, PA 15224 USA
关键词
D O I
10.1016/j.adro.2023.101176
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Bone metastases are common, occurring in 60% to 70% of patients with advanced malignancies. Historically, bone-directed radiation therapy regimens of 30 Gy over 10 fractions were used. However, prospective randomized data suggest equivalent pain relief with shorter-course regimens. The American Society for Radiation Oncology Choosing Wisely Campaign encourages clinicians to consider shorter-course palliative regimens in patients with limited prognosis. A retrospective analysis was performed to assess patterns of short-course and single-fraction radiation therapy during the past 5 years.Methods and Materials: We queried our electronic medical record (MOSAIQ) from 2016 to 2020 for patients with bone metastases who received palliative radiation therapy. Patients receiving >10 fractions or Medicare-approved palliative courses of radiation (30 Gy/10 fractions, 24 Gy/6 fractions, 20 Gy/5 fractions, 8 Gy/1 fraction) were included. Treatment department was defined as academic (n = 2) versus community (n = 12). Short-course treatment was defined as <6 fractions, whereas long-course included patients receiving >10 fractions. Patients were subdivided based on age and disease site. Physicians were grouped according to their year of residency completion. Multivariable logistic regression analysis identified predictors of short-course and single-fraction treatment.Results: We identified 1004 patients with 1768 bony metastases meeting inclusion criteria. The spine was the most common site, followed by pelvis/hip, extremity, and other site. Use of short-course treatment increased from 40% in 2016 to 50% in 2020. Single-fraction treatment increased from 7% in 2016 to 11% in 2020. Predictors of shorter courses included treatment at academic centers, more recent treatment, patient age >76 years, and nonspine anatomic site. Predictors of single-fraction treatment included treatment at academic centers, treating physician residency completion after 2010, patient age >76 years, and treatment to extremity or other site.Conclusions: Rates of short-course and single-fraction bone-directed radiation therapy increased within our health system over time. Treatment receipt at academic centers was associated with both short-course and single-fraction regimens. Physicians completing residency after 2010 were more likely to deliver single-fraction therapy.(c) 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:5
相关论文
共 48 条
  • [31] Randomized clinical trial comparing two schedules of bone metastases treatment: 30 Gy multifraction "vs" 8 Gy single fraction
    Arnalot, PF
    Algara, M
    Valls, A
    Ferrer, F
    Sanz, X
    Rodriguez, N
    Aunon, C
    Reig, A
    Lacruz, M
    Quera, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S208 - S208
  • [32] Single-fraction stereotactic versus standard conventional multifraction radiation for predominantly non-spine bone metastases:A randomized phase II trial.
    Quynh Nguyen
    Chow, Edward
    Chun, Stephen G.
    Liao, Zhongxing X.
    Fnu, Rensi
    Welsh, James William
    Hahn, Stephen
    Fuller, Clifton David
    Moon, Bryan
    Bird, Justin E.
    Satcher, Robert L.
    Lin, Patrick P.
    Jeter, Melenda
    O'Reilly, Michael
    Lewis, Valerae O.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Programmatic Comparison and Dissemination of an Audit of Single-fraction Radiation Therapy Prescribing Practices for Bone Metastases is Associated with a Meaningful and Lasting Change in Practice on a Population Level
    Olson, Robert
    Chan, Matthew
    Minhas, Neelam
    Kandola, Gurkirat
    Tiwana, Manpreet
    Lefresne, Shilo
    Halperin, Ross
    Schellenberg, Devin
    Wai, Elaine
    Ahmed, Nissar
    Tyldesley, Scott
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (02): : 325 - 329
  • [34] Breaking Barriers to Better Care: A Narrative Review on the Adoption of Single-Fraction Palliative Radiotherapy for Bone Metastases in Low- and Middle-Income Countries
    Galietta, Erika
    Donati, Costanza M.
    Vadala', Maria
    Cellini, Francesco
    Bomboka, Von Kaganda
    Rossi, Romina
    Buwenge, Milly
    Wondemagegnehu, Tigeneh
    Deressa, Biniyam Tefera
    Uddin, A. F. M. Kamal
    Sumon, Mostafa A.
    Maltoni, Marco
    Morganti, Alessio G.
    PALLIATIVE MEDICINE REPORTS, 2025, 6 (01): : 122 - 128
  • [35] What did COVID-19 pandemics teach us about single-fraction radiotherapy for painful bone metastases-State of the art or undertreatment?
    Arsenijevic, Tatjana
    Stepanovic, Aleksandar
    Milosevic-Maracic, Brankica
    Poparic-Bandjur, Bojana
    Miskovic, Ivana
    Gavrilovic, Dusica
    Nikitovic, Marina
    CANCER MEDICINE, 2023, 12 (15): : 15912 - 15921
  • [36] IMPACT OF DISSEMINATION OF CHOOSING WISELY CANADA (CWC) RECOMMENDATIONS ON UTILIZATION OF PALLIATIVE SINGLE FRACTION (SFRT) FOR BONE METASTASES IN MANITOBA
    Hanumanthappa, Nikesh
    Ong, Aldrich
    Chung, Youn Tae
    Beck, James
    Koul, Rashmi
    Bashir, Bashir
    Cooke, Andrew
    Nashed, Maged
    Dubey, Arbind
    Hunter, William
    Kim, Julian
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S92 - S92
  • [37] Comparison Between Short Course (Single Fraction) and Long Course (Multiple Fractions) on Pain Relief in Patients With Bone Localization of Multiple Myeloma
    Cassuto, O.
    Lenain, P.
    Nkhali, L.
    Tilly, H.
    Dubray, B.
    Benyoucef, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S680 - S680
  • [38] Randomized clinical trial comparing two schedules of bone metastases treatment:: 30 Gy multifraction vs. 8 Gy single fraction
    Foro, P.
    Algara, M.
    Valls, A.
    Carles, J.
    Rodriguez, N.
    Sanz, X.
    Ferrer, F.
    Gomez, D.
    Vinals, P.
    EJC SUPPLEMENTS, 2005, 3 (02): : 385 - 386
  • [39] High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial
    Harald Rief
    Sonja Katayama
    Thomas Bruckner
    Stefan Rieken
    Tilman Bostel
    Robert Förster
    Ingmar Schlampp
    Robert Wolf
    Jürgen Debus
    Florian Sterzing
    Trials, 16
  • [40] High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial
    Rief, Harald
    Katayama, Sonja
    Bruckner, Thomas
    Rieken, Stefan
    Bostel, Tilman
    Foerster, Robert
    Schlampp, Ingmar
    Wolf, Robert
    Debus, Juergen
    Sterzing, Florian
    TRIALS, 2015, 16